StockClub

ALNY

ALNYAlnylam Pharmaceuticals, Inc.$ --
Alnylam Pharmaceuticals, Inc.

Alnylam Pharmaceuticals, Inc.

ALNY

$ -

-

Review earnings summary, surprise history, and upcoming forecasts.

wallet
Earnings Summary
Updated: 12/31/2025FY2025 Q4
Revenue
1,097M USD
YoY +84.9%
Operating Income
132M USD
YoY +225.3%
Net Income
186M USD
YoY +322.6%
EPS
1.41$
YoY +316.9%

Revenue

$3.7B
FY2024 Q1$494.3M
$494.3M
Q1
FY2024 Q2$1.2B
$1.2B
Q2
FY2024 Q3$1.7B
$1.7B
Q3
FY2024 Q4$2.2B
$2.2B
Q4
FY2025 Q1$594.2M
$594.2M
Q1
FY2025 Q2$1.4B
$1.4B
Q2
FY2025 Q3$2.6B
$2.6B
Q3
FY2025 Q4$3.7B
$3.7B
Q4
Actual
+$1.5B (+65.2%)

Net Income

$313.7M
FY2024 Q1$-65.9M
$-65.9M
Q1
FY2024 Q2$-82.8M
$-82.8M
Q2
FY2024 Q3$-194.4M
$-194.4M
Q3
FY2024 Q4$-278.2M
$-278.2M
Q4
FY2025 Q1$-57.5M
$-57.5M
Q1
FY2025 Q2$-123.8M
$-123.8M
Q2
FY2025 Q3$127.3M
$127.3M
Q3
FY2025 Q4$313.7M
$313.7M
Q4
Actual
+$591.9M (+212.8%)

Surprise History

Actual RevenueAnalyst Estimate
FY2020BEAT
Actual:$492.9M
Est:$475.3M
FY2020BEAT
$492.9M
FY2021BEAT
Actual:$844.3M
Est:$820.8M
FY2021BEAT
$844.3M
FY2022BEAT
Actual:$1B
Est:$1B
FY2022BEAT
$1B
FY2023MISS
Actual:$1.8B
Est:$2.3B
FY2023MISS
$1.8B
FY2024BEAT
Actual:$2.2B
Est:$2.2B
FY2024BEAT
$2.2B
FY2025MISS
Actual:$3.7B
Est:$3.8B
FY2025MISS
$3.7B

Analyst Estimates